PCI Biotech Holding ASA – OSE:PCIB.OL
PCI Biotech Holding ASA stock price today
PCI Biotech Holding ASA stock price monthly change
PCI Biotech Holding ASA stock price quarterly change
PCI Biotech Holding ASA stock price yearly change
PCI Biotech Holding ASA key metrics
Market Cap | 83.80M |
Enterprise value | 7.07M |
P/E | -0.8 |
EV/Sales | N/A |
EV/EBITDA | -0.10 |
Price/Sales | N/A |
Price/Book | 1.14 |
PEG ratio | -0.01 |
EPS | -0.70 |
Revenue | N/A |
EBITDA | -31.32M |
Income | -26.13M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePCI Biotech Holding ASA stock price history
PCI Biotech Holding ASA stock forecast
PCI Biotech Holding ASA financial statements
| Dec 2022 | 0 | -6.33M | |
|---|---|---|---|
| Mar 2023 | 0 | -5.53M | |
| Jun 2023 | 0 | -5.75M | |
| Dec 2023 | 0 | -8.51M |
| Dec 2022 | 63482000 | 6.07M | 9.58% |
|---|---|---|---|
| Mar 2023 | 57615000 | 5.45M | 9.47% |
| Jun 2023 | 52518000 | 5.61M | 10.69% |
| Dec 2023 | 44050000 | 4.97M | 11.29% |
| Dec 2022 | -10.44M | 1K | -152K |
|---|---|---|---|
| Mar 2023 | -5.36M | 0 | -111K |
| Jun 2023 | -5.48M | 0 | -59K |
| Dec 2023 | 374K | 0 | 0 |
PCI Biotech Holding ASA alternative data
| Aug 2023 | 10 |
|---|---|
| Sep 2023 | 10 |
| Oct 2023 | 6 |
| Nov 2023 | 6 |
| Dec 2023 | 6 |
| Jan 2024 | 6 |
| Feb 2024 | 6 |
| Mar 2024 | 6 |
| Apr 2024 | 6 |
| May 2024 | 6 |
| Jun 2024 | 6 |
| Jul 2024 | 6 |
PCI Biotech Holding ASA other data
| Insider | Compensation |
|---|---|
Dr. Per Walday (1960) Chief Executive Officer | $2,900,000 |
Mr. Ronny Skuggedal (1976) Chief Financial Officer | $2,870,000 |
Dr. Amir Snapir M.D., Ph.D. (1961) Chief Medical Officer | $2,130,000 |
Ms. Kristin Eivindvik (1961) Chief Devel. Officer | $1,760,000 |
Mr. Ludovic Robin M.B.A., Pharm.D. (1965) Chief Bus. Officer | $1,730,000 |
Dr. Anders Høgset (1954) Chief Scientific Officer | $1,630,000 |
-
What's the price of PCI Biotech Holding ASA stock today?
One share of PCI Biotech Holding ASA stock can currently be purchased for approximately $13.9.
-
When is PCI Biotech Holding ASA's next earnings date?
Unfortunately, PCI Biotech Holding ASA's (PCIB.OL) next earnings date is currently unknown.
-
Does PCI Biotech Holding ASA pay dividends?
No, PCI Biotech Holding ASA does not pay dividends.
-
How much money does PCI Biotech Holding ASA make?
PCI Biotech Holding ASA has a market capitalization of 83.80M.
-
What is PCI Biotech Holding ASA's stock symbol?
PCI Biotech Holding ASA is traded on the OSE under the ticker symbol "PCIB.OL".
-
What is PCI Biotech Holding ASA's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of PCI Biotech Holding ASA?
Shares of PCI Biotech Holding ASA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are PCI Biotech Holding ASA's key executives?
PCI Biotech Holding ASA's management team includes the following people:
- Dr. Per Walday Chief Executive Officer(age: 65, pay: $2,900,000)
- Mr. Ronny Skuggedal Chief Financial Officer(age: 49, pay: $2,870,000)
- Dr. Amir Snapir M.D., Ph.D. Chief Medical Officer(age: 64, pay: $2,130,000)
- Ms. Kristin Eivindvik Chief Devel. Officer(age: 64, pay: $1,760,000)
- Mr. Ludovic Robin M.B.A., Pharm.D. Chief Bus. Officer(age: 60, pay: $1,730,000)
- Dr. Anders Høgset Chief Scientific Officer(age: 71, pay: $1,630,000)
-
How many employees does PCI Biotech Holding ASA have?
As Jul 2024, PCI Biotech Holding ASA employs 6 workers.
-
When PCI Biotech Holding ASA went public?
PCI Biotech Holding ASA is publicly traded company for more then 17 years since IPO on 23 Jun 2008.
-
What is PCI Biotech Holding ASA's official website?
The official website for PCI Biotech Holding ASA is pcibiotech.com.
-
How can i contact PCI Biotech Holding ASA?
PCI Biotech Holding ASA can be reached via phone at +47 67 11 54 00.
PCI Biotech Holding ASA company profile:
PCI Biotech Holding ASA
pcibiotech.comOSE
10
Biotechnology
Healthcare
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.
Oslo, 0379
:
ISIN: NO0010405640
:
